KaydedilenlerDerginizi ekleyin

Dergiler / The European Research Journal / 2018 / Cilt: 4 - Sayı: 1

Inflammation-related cancer or cancer-related inflammation

Shrihari T.G
Sayfa
1–5
Yayın Tarihi
2022-10-18
DOI
—
🏛️Bu makalenin bibliyografik verileri ve tam metin bağlantısı DergiPark üzerinden sağlanmıştır.
DergiPark Kaydı ↗
✨

Yapay Zeka Hızlı Bakış & Çıkarımlar

AI Insight
⚡ TL;DR(1 Cümlede Hızlı Çıkarım)

This article highlights about the role ofinflammation and oncogenes activate inflammatory mediators in tumor progression

📌 3 Maddede Bu Makale

🎯
Amaç & Hipotez:Inflammation is the body’s defensive action against various stimuli such as physical or chemical or infectiousagents.
📊
Temel Bulgular & Veri:If the inflammation aggravateschronically, non-resolved, dysregulated immune system, results release of various inflammatory mediatorssuch as free radicals (ROS and RNS), cytokines, chemokines, growth factors and proteolytic enzymes producedby innate and adaptive immune cells activate transcriptional factors (NF-KB,STAT3 and HIF-1α) results incell proliferation, angiogenesis, immunosuppression, genetic instability, invasion and metastasis.
💡
Sonuç & Katkı:This article highlights about the role ofinflammation and oncogenes activate inflammatory mediators in tumor progression
🔬Tür:Araştırma Makalesi
📍Kapsam:Genişletilmiş Akademik Örneklem
⚙️Değişkenler:Alan Parametreleri

Abstract

Inflammation is the body’s defensive action against various stimuli such as physical or chemical or infectiousagents. Acute inflammation and their mediators help in tissue repair and healing. If the inflammation aggravateschronically, non-resolved, dysregulated immune system, results release of various inflammatory mediatorssuch as free radicals (ROS and RNS), cytokines, chemokines, growth factors and proteolytic enzymes producedby innate and adaptive immune cells activate transcriptional factors (NF-KB,STAT3 and HIF-1α) results incell proliferation, angiogenesis, immunosuppression, genetic instability, invasion and metastasis. Oncogenesrelated to cancer activate inflammatory mediators such as chemokines and cytokines, which alters theinflammatory tumor microenvironment, promotes tumor progression. This article highlights about the role ofinflammation and oncogenes activate inflammatory mediators in tumor progression

🔖

Bu Makaleye Atıf Yap

T.G, S. (2022). Inflammation-related cancer or cancer-related inflammation. The European Research Journal, Cilt: 4 - Sayı: 1, 1–5. https://ajindex.com/articles/597733

📄 Tam Metin PDF Okuyucu

📄

PDF görüntüleyici hazırlanıyor...

Kaynakça (17)

  1. Grivennikov SI, Greten FR, Karin M. Immunity, inflammation and cancer. Cell 2010;140:883-99
  2. Shalapour S, Karin M. Immunity, inflammation, and cancer: an eternal fight between good and evil. J Clin Invest 2015;125:3347-55
  3. Maciel TT, Moura IC, Hermine O. The role of mast cells in cancers. F1000Prime Rep 2015;7:9
  4. Shrihari TG. Dual role of inflammatory mediators in cancer. Ecancermedicalscience 2017;11:721
  5. Korniluk A, Koper O, Kemona H, Dymicka-Piekarska V. From inflammation to cancer. Ir J Med Sci 2017:186;57-62
  6. Okada F. Inflammation-related carcinogenesis: current findings epidemiological trends, causes and mechanisms. Yonago Acta Medica 2014:57:65-72
  7. Tomasetti C, Vogelstein B. Cancer etiology. Variation in cancer risk among tissues can be explained by the number of stem cell divisions. Science 2015;347:78-81
  8. Allavena P, Germano G, Marchesi F, Mantovani A. Chemokines in cancer related inflammation. Exp Cell Res 2011;317:664-73
  9. Colotta F, Allavena P, Sica A, Garlanda C, Mantovani A. Cancer-related inflammation, the seventh hallmark of cancer: links to genetic instability. Carcinogenesis 2009;30:1073-81
  10. Schumacher TN, Schreiber RD. Neoantigens in cancer immunotherapy. Science 2015;348:69-74
  11. Chai EZ, Siveen KS, Shanmugam MK, Arfuso F, Sethi G. Analysis of the intricate relationship between chronic inflammation and cancer. Biochem J 2015;468:1-15
  12. Katoh H, Watanabe M. Myeloid-derived suppressor cells and therapeutic strategies in cancer. Mediators Inflamm 2015;2015:159269
  13. Noy R, Pollard JW. Tumor-associated macrophages: from mechanisms to therapy. Immunity 2014;41:49-61
  14. Nagasaki T, Hara M, Nakanishi H, Takahashi H, Sato M, Takeyama H. Interleukin-6 released by colon cancer-associated fibroblasts is critical for tumour angiogenesis: anti-interleukin-6 receptor antibody suppressed angiogenesis and inhibited tumourstroma interaction. Br J Cancer 2014;110:469-78
  15. Broz ML, Binnewies M, Boldajipour B, Nelson AE, Pollack JL, Erle DJ, et al. Dissecting the tumor myeloid compartment reveals rare activating ntigen-presenting cells critical for T cell immunity. Cancer Cell 2014;26:638-52
  16. Houghton AM. The paradox of tumor-associated neutrophils: fueling tumor growth with cytotoxic substances. Cell Cycle 2010;9:1732-7
  17. Putoczki TL, Thiem S, Loving A, Busuttil RA, Wilson NJ, Ziegler PK, et al. Interleukin-11 is the dominant IL-6 family cytokine during gastrointestinal tumorigenesis and ca